Home > Insider Trading > Filing (0001209191-22-058874)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1831363	Terns Pharmaceuticals Inc.	TERN	()	E9

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1764435	Lav Biosciences Fund V, L.p.	Room 606-7, St. George'S Bldg. 2 Ice House Street, Central Hong Kong K3 00000	No	No	Yes	No
1844154	Ltd Venture Spring Oriental	Room 606-7, St. George'S Bldg. 2 Ice House Street, Central Hong Kong K3 00000	No	No	Yes	No
1844158	Ltd Holdings Resources Hopewell	Room 606-7, St. George'S Bldg. 2 Ice House Street, Central Hong Kong K3 00000	No	No	Yes	No
1844279	Ltd Aqua Lav	Room 606-7, St. George'S Bldg. 2 Ice House Street, Central Hong Kong K3	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-11-23	1,000,000	$5.50	405,583	No	4	S	Indirect	See footnotes
Common Stock	Disposition	2022-11-23	333,334	$5.50	1,059,523	No	4	S	Indirect	See footnotes
Common Stock	Disposition	2022-11-23	166,666	$5.50	529,762	No	4	S	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,286,698	Indirect	See footnotes

Footnotes

Shares held by LAV Biosciences Fund V, L.P.
LAV Corporate GP, Ltd. is the general partner of LAV GP III, L.P., which is the general partner of the parent entity of Hopewell Resources Holdings Limited and Oriental Spring Venture Limited. LAV Corporate IV GP, Ltd., is the general partner of LAV GP IV, L.P., which is the general partner of the parent entity of LAV Aqua Limited. LAV Corporate V GP, Ltd., is the general partner of LAV GP V, L.P., which is the general partner of LAV Biosciences Fund V, L.P. Dr. Yi Shi is the managing partner of LAV Corporate GP, Ltd., LAV Corporate IV GP, Ltd., and LAV Corporate V, L.P. and has all voting and investment power with respect to shares beneficially held by each of Hopewell Resources Holdings Limited, Oriental Spring Venture Limited, LAV Aqua Limited and LAV Biosciences Fund V, L.P. Dr. Yi Shi is a managing partner at Lilly Asia Ventures.
Shares held by Hopewell Resources Holdings Limited.
Shares held by Oriental Spring Venture Limited.
Shares held by LAV Aqua Limited.